Residual effects of cannabis-use on neuropsychological functioning

Publikation: Beitrag in FachzeitschriftForschungsartikelBeigetragenBegutachtung

Beitragende

  • Lena Kristin Wendel - , Berliner Institut für Gesundheitsforschung in der Charité (Autor:in)
  • Laura Daedelow - , Berliner Institut für Gesundheitsforschung in der Charité (Autor:in)
  • Jakob Kaminski - , Berliner Institut für Gesundheitsforschung in der Charité (Autor:in)
  • Tobias Banaschewski - , Universität Heidelberg (Autor:in)
  • Sabina Millenet - , Universität Heidelberg (Autor:in)
  • Arun L.W. Bokde - , Trinity College Dublin (Autor:in)
  • Erin Burke Quinlan - , King's College London (KCL) (Autor:in)
  • Sylvane Desrivières - , King's College London (KCL) (Autor:in)
  • Herta Flor - , Universität Heidelberg, Universität Mannheim (Autor:in)
  • Antoine Grigis - , Commissariat à l’énergie atomique et aux énergies alternatives (CEA) (Autor:in)
  • Hugh Garavan - , University of Vermont (Autor:in)
  • Penny Gowland - , University of Nottingham (Autor:in)
  • Andreas Heinz - , Charité – Universitätsmedizin Berlin (Autor:in)
  • Rüdiger Brühl - , Physikalisch-Technische Bundesanstalt (Autor:in)
  • Jean Luc Martinot - , INSERM - Institut national de la santé et de la recherche médicale, École normale supérieure Paris-Saclay (Autor:in)
  • Eric Artiges - , INSERM - Institut national de la santé et de la recherche médicale, École normale supérieure Paris-Saclay, EPS Barthélémy Durand (Autor:in)
  • Frauke Nees - , Universität Heidelberg, Universitätsklinikum Schleswig-Holstein Campus Kiel (Autor:in)
  • Dimitri Papadopoulos Orfanos - , Commissariat à l’énergie atomique et aux énergies alternatives (CEA) (Autor:in)
  • Tomáš Paus - , Bloorview Research Institute (Autor:in)
  • Luise Poustka - , Georg-August-Universität Göttingen (Autor:in)
  • Juliane H. Fröhner - , Klinik und Poliklinik für Psychiatrie und Psychotherapie, Neuroimaging Center (Autor:in)
  • Michael N. Smolka - , Neuroimaging Center, Klinik und Poliklinik für Psychiatrie und Psychotherapie (Autor:in)
  • Robert Whelan - , Trinity College Dublin (Autor:in)
  • Gunter Schumann - , King's College London (KCL), Leibniz Institute for Neurobiology, Fudan University (Autor:in)
  • Henrik Walter - , Berliner Institut für Gesundheitsforschung in der Charité (Autor:in)

Abstract

Non-acute effects of cannabis on neurocognition in adolescents remain unclear with most studies being cross-sectional. Therefore, the aim of this longitudinal, multi-center study was to examine the effects of cannabis use on cognitive abilities in participants emerging into adulthood. Data on substance use as well as neurocognitive measures were assessed in 804 adolescents (441 females, 363 males) at age 14 and 19. First, cross-sectional analyses of baseline and follow-up data were conducted using analyses of covariance (ANCOVA). Second, repeated measures ANCOVAs were conducted to quantify longitudinal change. Cross-sectionally, we detected no significant neurocognitive differences before initiation of drug use. However, after controlling for confounders, light cannabis use as well as late-onset thereof was associated with increased decision-making skills both cross-sectionally at follow-up as well as longitudinally compared to non-using controls. In summary, our data suggests that decision-making is not impaired when cannabis is used in moderation and onset of use occurs after the age of 15. In addition, we find no evidence to support the presumption that cannabis consumption leads to a decline in neurocognitive ability.

Details

OriginalspracheEnglisch
Aufsatznummer101072
FachzeitschriftCognitive Development
Jahrgang59
PublikationsstatusVeröffentlicht - 1 Juli 2021
Peer-Review-StatusJa

Externe IDs

ORCID /0000-0001-5398-5569/work/161890709
ORCID /0000-0002-8493-6396/work/161891636

Schlagworte

Schlagwörter

  • Adolescence, Brain development, Cannabis, Decision-making, Marijuana, Neurocognition